Overview of Vaccines & Epidemiology of Vaccine Related Disease Flashcards

1
Q

What is the general spead of vaccine coverage?

A
  • Limited no of vaccines
    • Many reasons
    • Logistics
    • Cost
    • Cold chain
  • More vaccines in HICs than LMICs
  • Vaccine coverage reflect local disease epidemiology
  • As diseases go under control vaccine coverage could decrease
  • Vaccine schedules differ across countries
  • Child and adult schedules
  • In LICs there is limited differentiation between child and adult vaccination
  • Must accelerate the introduction of important vaccines in LICs
  • Whole cell vaccines= LICs Acellular vaccines= HICs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is diptheria?

A
  • Infectious respiratory disease caused by toxigenic strains of bacteria Corynebacterium diphtheriae or Corynebacterium ulcerans
  • Transmitted via airborne droplets
  • Bacteria infect the throat + the skin
  • Incubation period:
    • 2-7 days before the disease occurs
  • Patients with untreated disease may be infectious for up to 4 weeks
  • Affects people of all ages- most serious in young infants and the elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the features of diptheria?

A
  • Early symptoms;
    • Mild fever
    • swollen neck glands
    • anorexia
    • malaise
    • cough
  • 2-3 days
    • Membrane of dead cells forms in the throat, tonsils, larynx or nose
    • May narrow or occlude the airway
      • lead to respiratory distress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the severe symptoms of diptheria?

A
  • Toxin can travel through bloodstream causing extensive organ damage, neurological and heart complications (arrhythmia)
  • Death occurs in 5-10% of cases
  • Milder infections can still occur in people who are partically vaccinated/ were vaccinated a long time ago
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe diptheria trends over the past century

A

High number of cases between 1914 and 1944

Decline is not all due to vaccine

There has been increased hygine, better public health resources , better access to public health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe diptheria vaccine coverage in infants

A

Access to DTP3 vaccine between the 80s and 2010s has increased

Greater than the WHO UNICEF estimates

  • Decline of cases over time
  • Vaccine coverage has fallen over the pandemic
  • This poses a public health concern if there would be a resurgence of the disease due to a decrease in vaccine coverage over the pandemic

Non uniform coverage globally

Countries like nigeria have les than 50% coverage of the DTP3 vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is tetanus?

A
  • Caused by bacterium Clostridium tetani
  • Non-communicable therefore vaccination required for protection (no herd immunity)
  • Tetanus is ubiquitous and will not be gotten rid of thus we must maintain their vaccination
  • Bacteria form spores that can survive in the environment for years
  • Tetanus may occur if a wound or cut is infected by soil or manure
  • Incubation:
    • period 4-21 days
  • Affects people of all ages
  • People who recover from tetanus do not have natural immunity therefore need to be immunised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the symptoms of tetanus?

A
  • Generalised

Initial: muscle stiffness of the jaw (“Lockjaw”) 50% cases

Later symptoms: neck stiffness, difficulty swallowing, stiffness of stomach muscles, muscle spasms, sweating and fever

Complications:

  • Fractures
  • Hypertension
  • Laryngospasm
  • Pulmonary embolism
  • Aspiration
  • Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where does neonatal tetanus occur?

A
  • More frequent in developing countries
  • Children still suffer with tetanus due to poor hygine
  • Infant born without protective passive immunity
  • Infection of the umbilical cord stump
  • High fatality rate without therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the reported cases of tetanus globally by year and gae between 1985 and 2017

A
  • numbers
  • In the Uk, most of the cases had occurred over the age of 65
  • This is largely associated with waning vaccine protection ( like women 65+ because they were less vaccinated than men.
  • Men received extra vaccines in ww2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the solution to tetanus?

A
  • WHO: 2 doses of TT during 1st pregnancy and 1 dose in each pregnancy until 5 doses
  • The maternal neonatal tetanus elimination program (through the WHO has vaccinated millions of pregnant women with the tetanus toxoid vaccine)
  • Over 70% have received the vaccine over the year
  • 47 countries eliminated MNT between 2000 and June 2020
  • Again, countries like nigeria have failed to eliminate tetanus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is pertussis?

A
  • Disease of the respiratory tract caused by Bordatella pertussis bacteria
  • Spread easily from person-to-person in droplets produced by coughing or sneezing
  • Most dangerous in children under 1 year, most severe in young infants
  • Incubation period 6-20 days with a range of 4 - 21 days
  • Infectious from 6 days after exposure to 3 weeks after onset of cough
  • Duration of illness can be 2-3 months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the symptoms of pertussis?

A
  • Called whooping cough
  • Lasts long time (many weeks)
  • Initially: _cold-like symptom_s - runny nose, watery eyes, sneezing, fever and a mild cough
  • Followed by: gradually worsening cough, which develops to paroxysms of coughing followed by characteristic whoop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the complications for pertussis?

A
  • Respiratory – collapsed lung and/or pneumonia
  • Neurological – lack of oxygen leading to altered consciousness, convulsions, permanent brain damage, death
  • Severe weight loss and dehydration due to vomiting
  • Sudden death - babies may stop breathing, apnoeic attacks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the vaccine methods for pertussis?

A
  • Whole cell vaccine (wP)suspension of whole killed Bordetella pertussis organisms
    • Effective
    • Associated with side effects because the vaccine includes antigens to trigger an immune response, but it also contains polysaccharides that cause other side effects (like fever, vomiting etc)
  • Acellular vaccines (aP) – contain 2, 3, or 5 highly purified components from the B pertussis organism
    • This only contains the antigens
    • Less likely to cause side effects
    • More likely for immunity to fade, compared to whole cell vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the notifications for whooping cough/pertussis?

A

Loss of vaccine coverage in the 1970s

Due to a paper claiming to show an association between vaccine and encephalitis

However this paper was disproven and vaccine coverage returned

17
Q

What is the effectiveness of the pertussis vaccine during pregnancy?

A
  • Lower incidence
  • Cyclycal nature of pertussis (occurs every few years)
  • Occurs at all age groups
  • Number of deaths in infants increased but the reasons are multifactorial
  • Relates to the acellular pertussis vaccine and the waning of immunity
  • Therefore, vaccinatio nduring pregnancy is needed
18
Q

When would you vaccinate to prevent pertussis

A

Vaccinate during pregnancy

Then more doses at 2, 3 and 4 months in age

Most cases in young infants were ocurring before the infant vaccine programme

If the infant vaccine programme didn’t do much to protect against pertussis, you must vaccinate during pregnancy

19
Q

Where is the distribution of the pertussis vaccine?

A

This vaccine is also the DTP3 vaccine (also used to protect against diptheria, tetanus and pertussis)

Coverage is the same as diptheria

You recieve the 3rd dose with the diptheria vaccine

It is the same problem (i.e., post COVID-19 pandemic, there was a lack of coverage in the pertussis vaccine)

20
Q

What is polio?

A
  • Three types of Polio (I II III)
  • Virus enters via the mouth
  • Replicates in pharynx and GI tract
  • Invades local lymph tissue
  • Enters blood stream and may infect cells of central nervous system causing aseptic meningitis
  • The infection we are most concerned about is the CNS infection
  • More rarely replicates in and destroys the motor neurones which activate the muscles (~1:100 infections)
21
Q

What are the dynamics of poliomyelitis>

A
  • Transmitted through contact with the faeces or pharyngeal secretions of an infected person
  • Incubation period: ranges from 3 – 21 days
  • Infectiousness: not precise but transmission is possible as long as virus is excreted
  • Virus can be excreted for up to six weeks in the faeces and two weeks in saliva
  • Most infectious immediately before and 1-2 weeks after onset of paralytic disease
22
Q

What is paralytic polio?

A
  • Less than 1% of all polio infections result in flaccid paralysis
  • Paralysis develops 1-10 days after prodromal illness and progresses for 2-3 days
  • The use of one or both arms or legs may be lost and breathing may not be possible without help of a respirator.
  • Respiratory assistance (respirators)
  • The degree of recovery varies from person to person
23
Q

The polio vaccine and polio notifications

A
  • Until Oct 2004, live polio vaccine, given by mouth was used in UK
  • Very effective and stimulates immune response in the blood and gut
  • Very rarely (1 in a million) vaccine virus reverts back to wild type causing Vaccine Associated Paralytic Polio (VAPP)
  • Cases of VAPP have been reported in recipients of OPV and in contacts of the recipients
  • Or immunocompromised
  • OPV replaced by Inactivated PolioVaccine (IPV) (more costly)
  • Since the inception of the Pol3 vaccine, Polio myelitis has declined as shown in the graph below: Coverage of the vaccine is also high
24
Q

Describe the difference between the cases of polio between 1988 and 2016

A

1988

  • 350 000 cases
  • 125 endemic countries
  • World Health Assembly voted to eradicate polio

2016

  • 34 cases reported
  • 3 endemic countries (including nigeria)
  • Instable/ war afflicted countries are still having polio
25
Q

What is measles? Causative organism? Spread? Incubation etc…

A
  • Extremely contagious viral illness caused by Morbillivirus
  • Most common in 1-4 year olds
  • Spread by contact with nose and throat secretions and in airborne droplets released when an infected person sneezes or coughs
  • Transmission period is from beginning of first symptoms to 4 days after appearance of the rash
  • Incubation: 7 to 18 days
26
Q

What are the symptoms of measles?

A
  • runny nose
  • cough
  • red and watery eyes and
  • small white spots inside the cheeks (Koplik’s spots

Followed by:

  • A slightly raised rash develops (brick red), spreading from the face and upper neck to the body and then to the hands and feet over a period of three days

Rash lasts 5-6 days

  • Loss of appetite and loose stools
  • High hospitalisation rate
27
Q

What are the best known complications of measles?

A
  • Complications occur in approximately 30% of reported cases
    • Infants, adults and immunocompromised are at highest risk of severe complications
  • Severe diarrhoea may be a problem especially for infants, causing dehydration (8 per 100 cases)
  • Pneumonia affects 1-6 per 100 cases and is the commonest cause of death
  • Otits media (7-9 per 100 cases), convulsions (1 in 200)
  • Encephalitis may also develop (1 per 1000 cases)
  • Subacute sclerosing panencephalitis (SSPE) is a rare but fatal complication of measles infection (1 per 25,000 all cases; 1 per 8000 <2yrs)
  • Death (1 in 5,000 cases in UK)
  • More common in LICs (malnourished children= deadly)
28
Q

What are the measles notifications?

A
  • Loss of confidence of the MMR vaccine
  • Andrew wakefield
    • He suggested that MMR could predispose children to autism
    • However, shortcuts were made in the paper
  • Therefore, vaccine coverage fell, especially in London

However, this was disproven and coverage arose again

29
Q

What the the vaccine associated with TB?

A
  • The BCG vaccine is needed in the case of TB
  • Most cases occurred between 25-29 years of age
  • Occurred in migrants
  • Caused reanalysis and revision of the programme
  • BCG most widely given vaccine in the world – 100 million doses given each year but no clear impact on TB globally.
  • Protection thought to last 15y – so will protection last long enough if given in infancy? Currently much research looking at improving the BCG vaccine - ?DNA vaccine would be better.
30
Q

Who is the BCG vaccine recommended for in the UK?

A

All babies, at or soon after birth, living in areas where the incidence of TB is 40/100,000 or greater

  • Some west London locations as well
  • Children (<16yrs) whose parents or grandparents have lived in a country with a TB prevalence of 40/100,000 or higher
  • Previously unvaccinated new immigrants from high prevalence countries countries for TB
  • Contacts of cases of TB
  • Travellers (<16yrs) to countries with high TB prevalence for >3m
  • Occupational e.g. Healthcare workers <35yrs